Executive record
Nathan J. Dowden
President and Chief Operating Officer at Entrada Therapeutics, Inc.
More
Alpha ID: alpha:person:nathan-j-dowdenVersion: public-0:d751713988987e9331980363e24189ceAs of: 2026-10-05
- Executive
Leadership, in context.
Connect capital, control, accountability, and evidence.
Explore the record
ResponsibilitiesInspect board appointments and committee mandates.ExperienceReview career history and qualifications in context.Economic interestsExamine disclosed incentives and ownership.Key Claims
- Professional RolePresident and Chief Operating Officer at Entrada Therapeutics, Inc.www.sec.gov
- Executive titleExecutive title: President and Chief Operating Officerwww.sec.gov
- Executive titleExecutive title: President, Chief Operating OfficerTRDA DEF 14A executive officers
- AI and ML experienceAI and ML experience: not identified in the cited filingTRDA DEF 14A executive officers
Biography
Nathan J. Dowden serves as President and Chief Operating Officer of Entrada Therapeutics, Inc.
Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.
Board service
Board service coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageExecutive career
- Current · dates not publishedPresident and Chief Operating Officer · Entrada Therapeutics, Inc.
- 2026 to end not publishedExecutive title: President, Chief Operating Officer · Organization not publishedTRDA DEF 14A executive officers
- Dates not publishedExecutive title: President and Chief Operating Officer · Organization not published
Claims
Compensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageConflicts and accountability
Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.
Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.
Evidence, history and coverage
Additional published Claims
Published evidence records
2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
TRDA DEF 14A executive officers
sec filing · Source published: Apr 24, 2026 · Retrieved: May 5, 2026
Supports 5 claims
- AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
- Executive company: Executive at Entrada Therapeutics, Inc. · Claim reviewed: May 5, 2026
- Executive title: Executive title: President, Chief Operating Officer · Claim reviewed: May 5, 2026
- Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026
Open source
sec def 14a · Source published: Apr 24, 2026 · Retrieved: Sep 13, 2026
Supports 2 claims
- Professional Role: President and Chief Operating Officer at Entrada Therapeutics, Inc. · Claim reviewed: Sep 13, 2026
- Executive title: Executive title: President and Chief Operating Officer · Claim reviewed: Sep 13, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-05
- Biography
- published
- Board service
- not observed
- Executive career
- published
- Education and qualifications
- not observed
- Compensation
- not observed
- Conflicts and accountability
- not observed
- Background screening
- out of scope